Other OTC Pharmaceuticals - Chad

  • Chad
  • In Chad, the revenue in the market Other OTC Pharmaceuticals reached US$2.12m in 2024.
  • Looking ahead, the market is projected to experience an annual growth rate of 1.55% (CAGR 2024-2029).
  • It is worth noting that in a global context, the in the United States generates the highest revenue, amounting to US$7,171.00m in 2024.
  • When considering the population size, the per person revenue in Chad stands at US$0.11 in 2024.
  • Chad's Other OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Chad has been experiencing steady growth in recent years.

Customer preferences:
Customers in Chad have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the lower cost compared to prescription drugs, and the increasing awareness of self-care and preventive healthcare practices. Customers in Chad are also becoming more health-conscious and are seeking OTC pharmaceutical products to address minor health issues and improve their overall well-being.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Chad is the increasing demand for vitamins and dietary supplements. As people become more health-conscious, they are seeking ways to supplement their diet and improve their overall nutrition. Vitamins and dietary supplements offer a convenient and affordable solution for individuals looking to meet their nutritional needs. This trend is expected to continue as the population becomes more aware of the importance of a balanced diet and its impact on overall health.Another trend in the market is the growing popularity of herbal and natural remedies. Customers in Chad are increasingly turning to herbal and natural products for the treatment of minor ailments and to promote general well-being. This shift can be attributed to a preference for traditional remedies and a desire for products that are perceived to be safer and have fewer side effects compared to synthetic pharmaceuticals. As a result, there has been an increase in the availability and variety of herbal and natural products in the market.

Local special circumstances:
Chad is a landlocked country in Central Africa with limited access to healthcare facilities, especially in rural areas. This has led to a reliance on self-care and home remedies for minor health issues. The availability of OTC pharmaceutical products allows individuals in Chad to address common health concerns without having to visit a healthcare professional. This convenience factor has contributed to the growth of the Other OTC Pharmaceuticals market in the country.

Underlying macroeconomic factors:
Chad has experienced economic growth in recent years, driven by sectors such as oil, agriculture, and construction. This has resulted in an increase in disposable income and improved living standards for many individuals in the country. As a result, people in Chad have more resources to spend on healthcare products, including OTC pharmaceuticals. The growing middle class in Chad is also contributing to the demand for OTC pharmaceuticals, as they seek to improve their quality of life and access healthcare products that were previously out of reach.In conclusion, the Other OTC Pharmaceuticals market in Chad is experiencing growth due to customer preferences for convenient and affordable healthcare solutions, including vitamins, dietary supplements, and herbal/natural remedies. The local special circumstances of limited access to healthcare facilities and the reliance on self-care also contribute to the demand for OTC pharmaceutical products. The underlying macroeconomic factors of economic growth and increased disposable income further support the growth of the market in Chad.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)